Skip to main content
Smart Investors Daily
HC

NASDAQ · HCAT

Health Catalyst, Inc.

Healthcare · Medical - Healthcare Information Services

$1.70

Down-$0.03 (-1.73%)

Updated Sep 13, 2026, 3:25 PM

SID Score

3.4/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
181.07M
P/E ratio
-1.78
Dividend yield
0.00%
52-week range
$0.96 – $3.62
Volume
264.26K
Avg. volume
637.29K

Price performance

HCAT price history

1M range · 19 trading sessions · Daily adjusted prices

HCAT closed at $1.70 after 19 trading sessions, up 0.00% for the selected period.

Last close
$1.70
Period change
+0.00%
Period low
$1.53
Period high
$1.73
Daily close
View OHLC price history
HCAT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 11, 2026$1.75$1.77$1.69$1.70264.26K
Sep 10, 2026$1.71$1.745$1.615$1.73677.29K
Sep 9, 2026$1.68$1.765$1.65$1.73582.43K
Sep 8, 2026$1.58$1.75$1.58$1.70690.58K
Sep 4, 2026$1.68$1.71$1.67$1.69401.89K
Sep 3, 2026$1.69$1.74$1.67$1.71221.96K
Sep 2, 2026$1.71$1.76$1.67$1.69701.61K
Sep 1, 2026$1.63$1.75$1.63$1.71496.68K
Aug 31, 2026$1.57$1.66$1.546$1.64280.19K
Aug 28, 2026$1.59$1.64$1.585$1.59207.3K
Aug 27, 2026$1.59$1.645$1.59$1.59189.78K
Aug 26, 2026$1.56$1.61$1.56$1.59237.82K
Aug 25, 2026$1.58$1.59$1.55$1.58353.82K
Aug 24, 2026$1.56$1.605$1.53$1.59822.31K
Aug 21, 2026$1.61$1.61$1.53$1.531.06M
Aug 20, 2026$1.68$1.715$1.63$1.63523.38K
Aug 19, 2026$1.72$1.80$1.69$1.69720.83K
Aug 18, 2026$1.70$1.78$1.70$1.71354.04K
Aug 17, 2026$1.82$1.8501$1.695$1.70570.22K

Latest HCAT news

The latest Smart Investors Daily articles mentioning HCAT.

HCAT research

Overview

Company profile and research snapshot.

Company profile

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$4.25
Implied upside
Analysts
HCAT recent ratings
DateFirmRatingTarget
Aug 21, 2026Canaccord GenuityHold
Aug 13, 2026Wells FargoEqual-Weight
Aug 11, 2026CitigroupNeutral
Jul 21, 2026Canaccord GenuityBuy
Jun 26, 2026Wells FargoEqual-Weight
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 8, 2026

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

Kohl brings public-company leadership and a record of successful transformation; Ben Albert to continue as Chief Business OfficerSALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company’s Board of Directors,

Yahoo · Aug 31, 2026

Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026. About Health Catalyst Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence c

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.